ORTEXORTEX News
Tracking LBRT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LB
Trader NoteLBRT

LBRT earnings arrive with shorts at a one-year high and the stock down 13% on the week

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 22:36

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Liberty Energy closed at $16.58 on Tuesday, down 13.2% over the past week, after Q3 results landed on October 22 with short interest already at its highest level in at least a year and the stock having shed 14% over the past month.

Short interest hit 10.5% of the free float by October 20, up roughly 15% over the past 30 days and back near the peaks of the trailing 12 months. The rebuild has been grinding and persistent: shorts trimmed sharply in mid-September, pulling shares short down to around 14.3 million, then steadily re-added through October to 17 million. Despite the elevated positioning, the borrow market offers them no friction at all. Cost to borrow is just 0.44%, and availability has widened sharply this week to over 1,300% of short interest, meaning the pool of lendable shares is more than thirteen times the current short position. The ORTEX short score is 50.5, sitting precisely at the midpoint of the 0-to-100 range and barely changed week on week, suggesting the rebuild in shorts reflects sector pessimism rather than a crowded, high-conviction tactical bet. Options traders remain relatively call-heavy: the put/call ratio is 0.30, modestly below its 20-day average of 0.36, and well off the October 1 reading of 0.45 that preceded this selloff. For all the short interest building, options positioning has not shifted meaningfully toward protection.

The Street's read on LBRT is bullish by consensus but the targets have been drifting lower. Morgan Stanley maintained Overweight last week while cutting its target from $30 to $28. Piper Sandler made the same move on Monday, trimming to $29 from $30 while keeping Overweight. Citi and UBS both lowered targets at the end of September, with UBS cutting the most aggressively, from $35 to $31, while keeping Buy. Barclays, the outlier in the recent run of changes, upgraded to Overweight and raised its target to $27 from $23 in late September. The mean target across the analyst group is $28.46 against a current price of $16.58, implying roughly 72% upside on paper. The EV/EBITDA multiple has compressed to 5.0x, down modestly over the past week and month, and price-to-book is at 1.46x. The company ranks in the 93rd percentile for EPS surprise and the 92nd for analyst recommendation divergence from consensus, both suggesting the Street is more positive on this name than its price action would imply. The factor picture is weaker on forward earnings: 30-day EPS momentum ranks in the 7th percentile, and the EV/EBIT score sits at just the 5th.

The bull case rests on record pump activity, vertical integration advantages, and an emerging power generation business targeting 3 gigawatts of capacity by 2029. The bear case is harder to dismiss right now: Q2 adjusted EBITDA of $151 million came in 99 basis points below the Street's margin estimate, management guided to only flat-to-up Q3 results, and the power buildout requires $5 to 6 billion of investment over three to four years while 2026 free cash flow is expected to run negative $908 million. Net debt is rising toward $736 million and the financing path is not settled.

Earnings history adds the sharpest context. The prior print in July sent the stock down 30.9% on the day and 28.6% over the following five days. The print before that fell 21.1% on the day and 31.3% over five sessions. That track record explains both why short sellers have been adding into this week's release and why the stock fell hard into the print even before the result was known. The peer group has moved in the same direction: PUMP fell 13.4% on the week, AESI dropped 20.9%, and ACDC lost 11.6%, so the selling is not isolated to Liberty Energy, but LBRT's own earnings history makes the setup more acute for this name specifically.

The specific thing to watch now is whether the Q3 result repeats the pattern of the previous two quarters, and whether short interest, already at its highest level in over a year with ample borrow available, continues to build or begins to unwind as the post-earnings picture becomes clearer.

Stocks in this article

See the live data behind this article on ORTEX.

Open LBRT on ORTEX →

How this article was generated

Generated
21 Oct 2026, 22:36
Data as of
21 Oct 2026, 22:36
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.